The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
AdventHealth opens a new clinic to care for patients with long COVID-19 and support COVID-related research
-
AdventHealth Introduces MR-guided Focused Ultrasound (MRgFUS) for Essential Tremor and Tremor-dominant Parkinson’s Disease
-
New AdventHealth Study Examines the Role of the Gut Microbiome in Efficacy of Immunotherapy Treatment for Gynecological Cancers
-
AdventHealth for Children One of First in Country to Use 7-D Surgical Navigation System to Enhance Pediatric Spine Surgery Safety
-
New Study Finds Ondansetron Use Associated with Lower COVID-19 Mortality
-
Recognizing 10 years of excellence and innovation at AdventHealth Center for Interventional Endoscopy
-
Researchers Explore Molecular Responses to Exercise in Groundbreaking Trial
-
AdventHealth Physician Appointed to Florida’s First Rare Disease Advisory Council